Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Mckesson (MCK) stock in plain English

Free brief · no signupStart here
MCKPublished Nov 12, 2026
Mckesson Corp
Healthcare · Medical Distribution
Distributes pharmaceuticals, medical supplies, and oncology care services to pharmacies, hospitals, and clinics.
Assets:
Over 100 distribution centersMoves pharmaceuticals and medical supplies daily across North America.
The US Oncology NetworkUnites more than 2,600 independent oncology providers across the country.
51,000 employees globallyStaffs operations across distribution, specialty healthcare, and prescription technology.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

46
OPS ScoreOperating finances
Latest quote
-2.05%$1,062.16
$122.63B
27.3×
$422.87B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 12, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was MCK. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Mckesson (MCK) do?

Mckesson Corp (MCK) is a U.S.-listed company in Healthcare (Medical Distribution). What it does: Distributes pharmaceuticals, medical supplies, and oncology care services to pharmacies, hospitals, and clinics. It supplies one-third of all prescription medicines used in North America through an extensive distribution network. It is worth $122.63B on the market and sold $422.87B over the last year.

Market cap
$122.63B
P/E ratio
27.3×
Annual sales
$422.87B
Sector
Healthcare
Industry
Medical Distribution
Brief updated
Nov 12, 2026

Brands and businesses behind MCK

  • Health Mart: Operates a nationwide franchise network of independent community pharmacies, earning fees and wholesale distribution revenue.
  • The US Oncology Network: Provides practice management and supply chain services to independent oncology clinics across the United States.
  • CoverMyMeds: Offers electronic prior authorization software connecting doctors, pharmacies, and insurers, charging transaction and software fees.
  • Ontada: Provides oncology data analytics and clinical software, selling research insights to pharmaceutical manufacturers and providers.

MCK’s flags, in plain English

Each flag is a number from Mckesson’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.

Capital Works Hard

Earns 76.7% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.

Still Climbing

Sales up 11.1% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Earnings Jumping

Profits up 17.4% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.

Runway Is Short

This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.

1 more green flag open with the free trial. Try it free for 7 days.

Questions about MCK

How big is Mckesson?

Mckesson’s market cap is $122.63B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $422.87B: what customers paid the company over the last year, before any costs.

What is MCK’s P/E ratio?

MCK’s P/E ratio is 27.3×. Investors pay about 27.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with MCK?

A very small number of massive retail customers, including CVS Health, account for a substantial majority of overall revenue. That is one risk on Mckesson’s card. Its first risk flag is Runway Is Short, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Mckesson’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. MCK’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card